Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix

J R Schafer1, B M Jesdale, J A George

  • 1TB/HIV Research Laboratory, International Health Institute, Brown University, Providence, RI 02912, USA.

Vaccine
|October 31, 1998
PubMed
Summary

This study identified new human leucocyte antigen (HLA) ligands from HIV-1 proteins that are conserved across strains. These findings may help develop vaccines that induce cross-reactive cytotoxic T lymphocytes (CTLs).